UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000003288
Receipt number R000003977
Scientific Title Phase I/II study of Cetuximab combined with S-1 and irrinotecan (CeIRIS) in KRAS wild type metastatic colorectal cancer patients refractory to treatment with oxaliplatin and fluoropyrimidine.
Date of disclosure of the study information 2010/03/04
Last modified on 2014/09/04 11:58:06

No. Disposal Last modified on Item of update
1 Insert 2010/03/04 15:51:21
2 Update 2011/10/04 22:13:10 Control
3 Update 2011/10/04 22:13:52 Trial characteristics_1
Trial characteristics_2
4 Update 2014/03/06 09:40:03 Email
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Post marketing survey by drug manufacture etc., specified by Japanese law.
Email1
5 Update 2014/09/04 10:59:43 Organization
Organization
Organization
Organization
6 Update 2014/09/04 11:58:06 Key inclusion criteria
Key inclusion criteria